Always needed to break into the medical community through word of mouth for clinic and hospital (but not much so for telehealth as clinician have no other option but to use ResAppDx if they wanted to do remote respiratory consultation).
"The continued use of ResAppDx in the clinic is providing us with valuable real-world evidence on the benefits of ResAppDx, and the clinic has additionally agreed to share and publish this evidence with the medical community"
- Forums
- ASX - By Stock
- RAP
- Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic
Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-52
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 181 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)